KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Buildings: 2010-2013

Historic Buildings for Biomarin Pharmaceutical (BMRN) over the last 4 years, with Dec 2013 value amounting to $159.1 million.

  • Biomarin Pharmaceutical's Buildings rose 9.97% to $159.1 million in Q4 2013 from the same period last year, while for Dec 2013 it was $159.1 million, marking a year-over-year increase of 9.97%. This contributed to the annual value of $159.1 million for FY2013, which is 9.97% up from last year.
  • As of FY2013, Biomarin Pharmaceutical's Buildings stood at $159.1 million, which was up 9.97% from $144.7 million recorded in FY2012.
  • In the past 5 years, Biomarin Pharmaceutical's Buildings registered a high of $159.1 million during FY2013, and its lowest value of $138.0 million during FY2010.
  • Its 3-year average for Buildings is $148.4 million, with a median of $144.7 million in 2012.
  • Data for Biomarin Pharmaceutical's Buildings shows a peak YoY climbed of 9.97% (in 2013) over the last 5 years.
  • Biomarin Pharmaceutical's Buildings (Yearly) stood at $138.0 million in 2010, then climbed by 2.51% to $141.5 million in 2011, then climbed by 2.27% to $144.7 million in 2012, then increased by 9.97% to $159.1 million in 2013.